Refractory Metastatic Colorectal Cancer
12 clinical trials · Condition
◉ Watch Refractory Metastatic Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer (NCT05213195) | Zhejiang University | 2021-12-10 |
| Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers (NCT05205330) | Rottapharm Biotech | 2021-11-23 |
| NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer (NCT05248048) | The Third Affiliated Hospital of Guangzhou Medical University | 2021-09-13 |
| Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients (NCT04737187) | Taiho Oncology, Inc. | 2020-11-25 |
| QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer (NCT04527068) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-09-20 |
Track Refractory Metastatic Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.